Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

By Jeffrey A. Cohen, Frederik Barkhof, G. Comi, H. Hartung, B. Khatri, X. Montalban, J. Pelletier, R. Capra, P. Gallo, G. Izquierdo and 7 more. New England Journal of Medicine, 2010

2,166 citations recorded by the source corpus.

Subfields: Molecular Biology, Neurology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/1d93b4a55ee31149443ec5ced8d6015f24afa0f0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. V. Brinkmann

Citations in the corpus

• Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis (2010, background): “5 mg dose; cell counts remained stable for the entire treatment perio”